Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04606381
Title	A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies (PALOMA)
Acronym	PALOMA
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Janssen Research & Development, LLC
Indications	hepatocellular carcinoma breast cancer malignant mesothelioma colorectal cancer ovarian cancer Advanced Solid Tumor lung non-small cell carcinoma gastroesophageal cancer medullary thyroid carcinoma head and neck squamous cell carcinoma renal cell carcinoma
Therapies	Amivantamab-vmjw + Lazertinib Amivantamab-vmjw + Lazertinib + rHuPH20 Amivantamab-vmjw Amivantamab-vmjw + rHuPH20
Age Groups:	adult \| senior
Covered Countries	USA \| GBR \| CAN